Progressive Care's EPS (Basic) for the
three
months ended in Dec. 2023 was $-2.14.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $-3.45.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 13 years, Progressive Care's highest 3-Year average EPS without NRI Growth Rate was 47.40% per year. The lowest was -22.60% per year. And the median was 10.10% per year.
Progressive Care EPS (Diluted) Historical Data
The historical data trend for Progressive Care's EPS (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Progressive Care's EPS (Diluted)
For the Pharmaceutical Retailers subindustry, Progressive Care's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Progressive Care's PE Ratio Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Progressive Care's PE Ratio distribution charts can be found below:
* The bar in red indicates where Progressive Care's PE Ratio falls into.
Progressive Care EPS (Diluted) Calculation
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
Progressive Care's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.45
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Progressive Care (OTCPK:RXMD) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Progressive Care EPS (Diluted) Related Terms
Thank you for viewing the detailed overview of Progressive Care's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
Progressive Care (Progressive Care) Business Description
Progressive Care Inc is a personalized healthcare services and technology company which provides prescription pharmaceutical services, risk management, and data analytics to healthcare organizations and providers. The company through its wholly-owned subsidiary Pharmco, provides prescription pharmaceuticals, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, and health practice risk management. It also offers certain disease testing and vaccinations. It offers services in a variety of languages, including English, Spanish, French, Creole, Portuguese, Ukrainian, and Russian.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RXMD has been successfully added to your 